43 results
DEFA14A
INVA
Innoviva, Inc.
17 May 23
Additional proxy soliciting materials
5:18pm
of Social Capital Suvretta Holdings Corp. II (Nasdaq: DNAB), a publicly traded special purpose acquisition company where she has been a director since 2021 … . Social Capital Suvretta Holdings Corp. II filed a Current Report on Form 8-K to such effect on May 16, 2023, which is incorporated herein by reference
SC TO-T
EX-99
INVA
Innoviva, Inc.
25 Jul 22
Third party tender offer statement
8:34am
:
(Include Zip Code)
(Tax Identification or Social Security Number)
☐ Credit Shares tendered by book-entry transfer that are not accepted … (full title):
Address:
(Include Zip Code)
Area Code and Telephone Number:
Email Address:
Tax Identification or Social Security No.:
GUARANTEE
8-K
EX-10.1
vj9ilo6z4nr
13 Jul 22
Entry into a Material Definitive Agreement
5:27pm
SC TO-C
EX-2.1
swt mw7ve543kt86
11 Jul 22
Information about tender offer
3:46pm
8-K
EX-2.1
ba1m3rzt4tk8l89 0kta
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
425
iiwtrxkfin4uxpjfy
11 Jul 22
Business combination disclosure
7:38am
SC TO-T
EX-99
blzuca vqro
7 Jun 22
Third party tender offer statement
9:04am
SC TO-C
EX-2.1
dqyp5mdwy9z4e
23 May 22
Information about tender offer
8:53pm
8-K
EX-2.1
vw7jm04
23 May 22
Tender and Support Agreement
8:51pm
8-K
EX-4.1
abw757c03jrlk f8b
8 Mar 22
Innoviva Announces Proposed Offering of $200 Million of Convertible Senior Notes
5:15pm
8-K
EX-10.2
piund5wfzphn1f6nd88t
4 Oct 18
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.1
7ea6j lrp5t3
4 Oct 18
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.1
fcy4 uv3cb6g6sw
8 Aug 18
Departure of Directors or Certain Officers
4:44pm
8-K
EX-10.3
xf1shx63gp
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.3
4drvpem
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
SC TO-I
EX-99
uynstuc03i2a6ri2c
1 Aug 07
Issuer tender offer statement
12:00am